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ABSTRACT
Malnutrition is a common condition in liver cirrhotic patients. Leptin regulates body weight
physiologically by suppressing appetite and increasing energy expenditure. Leptin is higher in female
than male. Studies have shown correlation between leptin with metabolic factors like body mass
index (BMI) and lipid profile in cirrhotic patients. This study was conducted to investigate the
correlation between serum leptin levels with lipid profile and free fatty acid in male patients with liver
cirrhosis. This was a cross sectional study that conducted at Gastroentero-Hepatology Clinic and
Internal Ward at Dr. Sardjito General Hospital, Yogyakarta. The inclusion criteria were patients with
liver cirrhosis > 18 years old, male, with Child-Pugh classification B and C, and provided informed
consent. The exclusion criteria were liver cirrhotic patients with comorbidity chronic kidney disease,
chronic heart failure, diabetic, cancer, infection/septic, pregnancy, breast feeding, and steroid use.
Data collecting was performed by anamnesis, physical examination, abdominal ultrasonography
examination, and blood chemistry test. Pearson test was used to evaluate the correlation between
the serum leptin level with the lipid profile and free fatty acid. The results showed that no significant
negative correlation was observed between the serum leptin level with the total cholesterol (r= -
0.052; p=0.766), high-density lipoprotein/HDL (r= -0.078; p=0.658)  and triglyceride (r= -
0.170; p=0.328) in male patients with liver cirrhosis. Furthermore, no significant positive correlation
was observed between the serum leptin levels with the low-density lipoprotein/LDL (r= -0.013; p=
0.942) and free fatty acid/FFA (r= 0.007; p=0.968). In conclusion, there was no correlation
between serum leptin levels with lipid profile and FFA in male patients with liver cirrhosis.
ABSTRAK
Malnutrisi merupakan keadaan yang sering terjadi pada penderita sirosis hati. Leptin secara fisiologi
mengatur berat badan dengan cara menekan nafsu makan dan meningkatkan pengeluaran energi.
Kadar leptin lebih tinggi pada wanita daripada laki-laki. Penelitian menunjukkan adanya hubungan
antara kadar leptin dengan beberapa faktor metabolisme seperti indeks massa tubuh (IMT) dan profil
lipid. Penelitian ini bertujuan untuk mengkaji hubungan antara kadar leptin serum dengan profil lipid
dan asam lemak bebas pada laki-laki penderita sirosis hati. Penelitian ini merupakan studi cohort
yang dilakukan di Poliklinik Gastroentero-Hepatologi dan Bangsal Ilmu Penyakit Dalam RSUP Dr.
Sardjito, Yogyakarta. Kriteria inklusi meliputi laki-laki penderita sirosis hati berumur > 18 tahun,
dengan klasifikasi Child-Pugh B dan C, serta bersedia ikut penelitian dengan menandatangani
lembar persetujuan penelitian. Kriteria eksklusi adalah penderita sirosis hati dengan gagal ginjal
kronik, gagal jantung kronik, diabetes mellitus, kanker, infeksi/sepsis, hamil, menyusui, dan
menggunakan steroid. Seleksi subjek dilakukan melalui anamnesis, pemeriksaan fisik, pemeriksaan
ultrasonografi abdomen, dan pemeriksaan kimia darah. Analisis adanya hubungan antara kadar
leptin serum dengan profil lipid dan asam lemak bebas menggunakan uji Pearson. Hasil penelitian
menunjukkan tidak ada hubungan negatif yang bermakna antara kadar leptin serum dengan kadar kolesterol
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total (r= -0,052; p=0,766), HDL (r= -0,078; p=0,658) dan trigliserida (r= -0,170; p=0,328)
pada laki-laki penderita sirosis hati. Selain itu juga terbukti tidak ada hubungan positif yang bermakna
antara kadar leptin serum dengan LDL (r=0,013; p=0,942) dan asam lemak bebas (r=0,007;
p=0,968). Dari penelitian ini dapat disimpulkan bahwa tidak ada hubungan antara kadar leptin
serum dengan profil lipid dan asam lemak bebas pada laki-laki dengan sirosis hati.
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INTRODUCTION
Chronic liver disease is a major health
problem in the world. Chronic liver disease
such as cirrhosis and hepatocellular carcinoma
contributes to an estimated 1.5 million deaths.
Patients with chronic liver disease showed
some symptoms such as weakness, anorexia,
malnutrition and weight loss.1 Malnutrition in
liver cirrhosis is influenced by several factors,
namely the existence of a metabolic disorder of
carbohydrate, protein, and fat, as well as
increased energy expenditure, impaired absorption
and digestion, and food intake are not adequate.2
Mechanism of malnutrition in liver cirrhosis is
not fully understood. Decreased food intake and
increasing energy expenditure is estimated to play
a role in negative energy balance in liver cirrhotic
patient.3 Several studies have shown that there
were increased levels of circulating serum leptin in
alcoholic cirrhosis. It provides evidence that leptin
is involved in malnutrition in cirrhosis.4
Leptin is a family of cytokines, mainly secreted
by adipocytes and is known to decrease food
intake. Leptin also has an important role in the
regulation of body weight in mamalia.1 Leptin level
is higher in female than in male. This occurs because
of differences in fat distribution in female who have
more subcutaneous fat and the effects of estrogen
and progesterone induction on leptin secretion.5
Some researchers find that leptin level
increases in cirrhosis patients.6 Cirrhosis is often
associated with hypermetabolism, and serum leptin
levels are found to increase significantly. Leptin
also plays a role in the pathogenesis of
symptoms such as body weakness.7 Moreover,
levels of cholesterol and triglycerides
decreased in cirrhosis. This is possibly related
to hepatic synthesis defects and malnutrition
known and reported as a complication in liver
cirrhosis patients. Decreasing cholesterol and
triglyceride levels in cirrhosis indicate a poor
prognosis.8
One of the causes of liver cirrhosis is chronic
hepatitis C. Liu et al.9 reported that serum leptin
levels increase in patients with chronic hepatitis C
affecting liver metabolic functions. Furthermore, a
close relationship between serum leptin levels and
fat metabolism and between hepatic
necroinflammation and lipid and fat metabolism in
the patients. This relationship may be not only
observed in patients with liver cirrhosis caused by
hepatitis C virus infection, but also observed in
other liver cirrhosis patients. Petrides et al.10
reported that liver cirrhosis is characterized by
several abnormalities in the circulation of
substances and concentrations of hormones such
as free fatty acid (FFA), glucagon, growth
hormone, norepineprin, and insulin. There was an
increased plasma FFA levels in patients with liver
cirrhosis after absorption despite hyperinsulinemia.
The increased lipid oxidation observed by some
researchers may reflect changes in nutritional intake
and catabolic processes.
This study was conducted to investigate the
correlation between serum leptin levels with lipid
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This was an observational study using cross
sectional design to evaluate the correlation between
serum leptin levels with lipid profile and free fatty
acids in patients with liver cirrhosis. Thirty five
patietns with liver cirrhosis in the outpatient of
Gastro-Hepatology Clinic admitted to the Internal
Medicine ward of Dr. Sardjito General Hospital,
Yogyakarta who met inclusion and exclusion
criteria were studied. The inclusion criteria were
liver cirrhosis Child B & C based on clinical
criteria, laboratory and ultrasonography, age of e”
18 years, male, has a complete medical record
and agreed to join this study by signing an informed
consent. The exclusion criteria were cirrhosis
patients coincident with renal failure, sepsis,
hepatocellular carcinoma, chronic heart failure,
diabetes mellitus and using steroid. This study was
approved by the Health Research Ethics
Committee of Faculty of Medicine, Universitas
Gadjah Mada, Yogyakarta.
Blood sample analysis
Fifteen mL of blood samples were obtained
from all patients after overnight fasting. Samples
were then centrifuged and serum were collected
and stored at -20 oC until analyzed. Serum leptin
levels were assayed using a commercial ELISA
kits (Human Leptin Quantikine ELISA Kit).
Serum total cholesterol, HDL cholesterol, LDL
cholesterol and triglyceride as well as FFA
were determined on an automatic analyzer
(Hitachi 7170A, Hitachi Koki Co., Ltd).
Statistical analysis
Data characteristics of subjects were
presented as mean ± standard deviations (SD).
Normality distribution of variables was determined
by the Shapiro-Wilk test. Correlation between
serum leptin levels with lipid profiles and FFA were
analyzed by Spearman if the data distribution was
not normal, and by Pearson analysis when data
distribution was normal. Statistical analysis
was considered significant when p value was
< 0.05 with 95% confidence interval.
RESULTS
A total of 42 male patients with liver
cirrhosis were recruited by sequential sampling
from October 2009 to October 2010. However,
only 35 of these patients met the inclusion and
exclusion criteria. The characteristic of patients
is presented in TABLE 1.
TABLE 1. Characteristics of patients with liver
cirrhosis (mean ± SD or frequency)
FFA: free fatty acid, HDL: high-density lipopreotein,
DL: low-density lipoprotein
No significant negative correlation was
observed between the serum leptin levels with the
total cholesterol, HDL and triglyceride (FIGURE
1) in male patients with liver cirrhosis. Furthermore,
no significant positive correlation was observed
between the serum leptin levels with the LDL and
FFA (FIGURE 1 and 2).
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FIGURE 1.  Correlation between serum leptin levels and lipid profiles in male patients with liver cirrhosis
FIGURE 2. Correlation between leptin levels and lipid
profiles in male patients with liver cirrhosis
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DISCUSSION
Studies concerning the incidence of liver
cirrhosis were reported by some authors.
Henriksen et al.6 reported that liver cirrhosis was
observed in 62.5% male patients. This result was
suported by study conducted by Ockenga et al.11
which found 65% in male patients and by Jian et
al.12 which found in 63.7% in male patients. A
study in the United Kingdom showed that the
incidence of liver cirrhosis in men were 50% higher
than in female (relative risk 1.52%, 95% CI 1.42-
1.63).13 It might due to the higher alcohol
cinsumption in male than in female.13 Prevalence
of liver cirrhosis in Indonesia has not been reported,
yet. However, the incidence of liver cirrhosis in
some academic hospital has been reported.14
Mean age of patients with liver cirrhosis in this
study was 51.09 ± 12.25 years old. The mean age
of patients with cirrhosis of the study by Henriksen
et al.6 was 53 ± 3 years, Orlando et al.14 was 55 ±
10 years, and Ockenga et al.11 was 48 ± 9 years.
Study by Kusumobroto15 had age range of 13-88
years old with liver cirrhosis largest group between
40-50 years. The most common causes of liver
cirrhosis in this study were hepatitis B (57.1%),
followed by alcoholic hepatitis (17.1%),
hepatitis C (8.7%), and others (non B non C)
(17.1%). This is consistent with the study
conducted by Gadhir et al.16 which showed that
cirrhosis was mostly caused by hepatitis B virus
(53%) and hepatitis C virus (8%).
The prevalence of hepatitis B in Indonesia
in 1997 was 9.7% for male and 9.3% for female
with the highest frequency in the age group 45-49
years of 11.9%, while hepatitis C was 0.8% with
the highest frequency in the age 55-59 years of
2.12%.17 This study showed the frequency of
patients with Child C was higher than those of with
Child B categories (54.3% vs 45.7%). Meanwhile,
Henriksen et al,6 found that the frequencies of
patients with Child A, Child B, and Child C
categories were 18.75%, 37.5% and 43.75%,
respectively. Ockenga et al.11 found that the
frequency of patients with Child A, Child B,
and Child C categories were 12.5%, 40%, and
47.5%, respectively. Child-Pugh classification
was used to assess the degree of liver disease
severity based on the degree of ascites, albumin,
bilirubin, prothrombin time, and the degree of
encephalopathy. The category was related with
1 and 2 years survival as follows: Child A of
85-100%, child B of 60-80%, and child C of
35-45%.18 Early stage of cirrhosis is often
asymptomatic so frequently discovered
accidentally during patient’s routine medical
examination or often found coincidentally in the
course of work-up for another illness.19
The mean serum leptin levels in this study was
12.03 ± 1.92 ng/mL. The results are consistent
with the results of Henriksen et al.6 Which found
that serum leptin levels of cirrhotic group was
7.3 ± 1.6 ng/mL and of control group was 2.6 ±
0.6 ng/mL, whereas Bolukbas et al.4 showed
mean serum leptin levels of cirrhotic gorup was
13.5 ng/mL and control group was 6.4 ng/mL.
The normal range of serum leptin levels in
healthy subjects is 3-5 ng/mL.20 Based on these
results, it is known that serum leptin levels in
patients with liver cirrhosis was higher than
normal subjects. The significant increase in
serum leptin levels in patients with liver
cirrhosis can be caused by liver stellate cells
which changed in liver cirrhosis that lead to
increase leptin expression. Moreover, the
increase in cytokines levels such as interleuki-
6 (IL-6) and tumor necrosis factor α (TNF-α)
can induce the production of leptin by adipocytes
cells and decrease the leptin renal
excretion.6,21,22
 The mean levels of lipid profiles in this
study were 134.90 ± 44.58 mg/dL for
cholesterol, 31.27 ± 15.05 mg/dL for HDL,
85.97 ± 34.89 mg/dL for LDL, and 88.28 ±
41.11 mg/dL for triglyceride. The results are
consistent with the results of the study by Ghadir
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et al.16 which found that level of lipid profile in
cirrhosis patients was lower than controls
(cholesterol: 138.9 vs 184.6 mg/dL; HDL: 40.7
vs 44.5 mg/dL; LDL: 80.5 vs 137.2 mg/dL;
triglyceride: 82.2 vs 187.8 mg/dL).
The mean level of FFA in this study was
0.73 ± 0.26 µmol.kg-1.min-1.This results is
consistent with the results of study conducted
by Shangraw and Jahoor23 which found an
increased FFA in cirrhosis patients compared
to controls (1.45 ± 0.18 vs 0.85± 0.17 ìmol.kg-
1.min-1). Furthermore, the study conducted by
Riggio et al.24 also found a higher FFA in
patients with liver cirrhosis compared to
controls (746.6 ± 46.29 vs 359.22 ± 40.82
µmol/L).
Shangraw and Jahoor23 reported that the
increase in FFA in cirrhosis patients is not only
caused by acceleration of lipolysis, but also due
to impairment of FFA into triglycerides in
adipocytes. However, the underlying mechanisms
of the impairment of  reesterification of FFA in
adipocytes of cirrhosis patients have not
understood, yet. The increase in plasma FFA levels
come from lipolysis of triacylglycerol in adipose
tissue or as result of lipoprotein lipase activity
during tha plasma triacylglycerols uptake from
adipose tissue.  It is found in combination with
albumin, with varying concentrations between 0.1
to 2.0 ìeq/mL in plasma.25
This study showed no significant negative
correlation between the serum leptin levels with
the lipid profile and FFA in male patients with liver
cirrhosis. Several studies concerning the correlation
between serum leptin levels with anthropometric
and metabolic parameters in patients with cirrhosis
have been reported with different results. Liu et
al.9 reported strong positive correlation
between serum leptin levels and body fat in
patients with chronic hepatitis C. Futhermore,
Myers et al.26 showed weak positive correlation
between serum leptin levels and triglycerides in
patients with hepatitis C.
Wongjitrat et al.27 reported no correlation
between serum leptin levels and degree of hepatic
fibrosis i.e. fibrosis, necroinflammation and steatosis
in patients with chronic hepatitis C.  Whereas
Gadhir et al.16 showed correlation between
degree of liver damage and total cholesterol, HDL,
and LDL in patients with cirrhosis, however, there
was no correlation  with triglycerides.  Watanabe
et al.28 reported strong positive correlation
between leptin with BMI and total body fat.
Furthermore, these studies conclude that increased
serum leptin levels are useful as a biomarker to
predict recurrence of hepatocellular carcinoma
(HCC) in patients with high risk of the male sex,
cirrhosis, high AFP, large tumor size, Hepatitis B
and C infection, and alcohol consumption.
Our results showed different results from other
studies. It might be caused by several limitations
in our study. First, our study was cross-sectional
design. Second, the limitation number of the
cirrhotic subjects caused by hepatitis C. Several
studies have shown the involvement of hepatitis C
on lipid metabolism. In this study, we only have 3
cirrhosis patients with hepatitis C.
CONCLUSION
In conclusion, there is no significant correlation
between leptin level and total cholesterol, HDL,
triglyceride, LDL and FFA in male patients with
lever cirrhosis in Yogyakarta, Indonesia. In
addition, further multicenter study with a larger
number of subject is necessary to clarify this
results.
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